Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version).
出版信息
Chin J Cancer Res. 2019 Feb;31(1):99-116. doi: 10.21147/j.issn.1000-9604.2019.01.06.
Abstract
摘要
相似文献
1
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version).中国临床肿瘤学会（CSCO）2018年分化型甲状腺癌持续/复发及转移诊疗指南（英文版）
Chin J Cancer Res. 2019 Feb;31(1):99-116. doi: 10.21147/j.issn.1000-9604.2019.01.06.
2
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version).中国临床肿瘤学会（CSCO）结直肠癌诊疗指南2018（英文版）
Chin J Cancer Res. 2019 Feb;31(1):117-134. doi: 10.21147/j.issn.1000-9604.2019.01.07.
3
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version).中国临床肿瘤学会（CSCO）头颈部癌诊疗指南2018（英文版）
Chin J Cancer Res. 2019 Feb;31(1):84-98. doi: 10.21147/j.issn.1000-9604.2019.01.05.
4
Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2022.中国临床肿瘤学会（CSCO）乳腺癌诊疗指南2022
Transl Breast Cancer Res. 2022 Apr 30;3:13. doi: 10.21037/tbcr-22-21. eCollection 2022.
5
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version).中国临床肿瘤学会（CSCO）恶性淋巴瘤诊疗指南2021（英文版）
Chin J Cancer Res. 2021 Jun 30;33(3):289-301. doi: 10.21147/j.issn.1000-9604.2021.03.01.
6
Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer.中国临床肿瘤学会（CSCO）：胰腺癌诊疗指南
J Natl Cancer Cent. 2022 Aug 23;2(4):205-215. doi: 10.1016/j.jncc.2022.08.006. eCollection 2022 Dec.
7
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南：美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
8
Comments to the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2022.对中国临床肿瘤学会（CSCO）《2022年乳腺癌诊疗指南》的点评
Transl Breast Cancer Res. 2022 Jul 30;3:21. doi: 10.21037/tbcr-22-31. eCollection 2022.
9
[Updates of Chinese Society of Clinical Oncology (CSCO) guideline for breast cancer in 2018].[中国临床肿瘤学会（CSCO）2018年乳腺癌诊疗指南更新]
Zhonghua Yi Xue Za Zhi. 2018 Apr 24;98(16):1213-1217. doi: 10.3760/cma.j.issn.0376-2491.2018.16.005.
10
Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor.《中国胃肠间质瘤诊断和治疗共识指南》
Chin J Cancer Res. 2017 Aug;29(4):281-293. doi: 10.21147/j.issn.1000-9604.2017.04.01.
引用本文的文献
1
Predictive nomogram for occult metastasis in central lymph nodes of papillary thyroid microcarcinoma based on clinical and ultrasound features.基于临床和超声特征的甲状腺微小乳头状癌中央区淋巴结隐匿性转移预测列线图
Gland Surg. 2025 Jul 31;14(7):1295-1305. doi: 10.21037/gs-2025-159. Epub 2025 Jul 28.
2
The prognostic implication of skip metastasis to lateral neck in patients with papillary thyroid cancer.甲状腺乳头状癌患者颈部侧方跳跃转移的预后意义。
Quant Imaging Med Surg. 2024 Dec 5;14(12):9477-9485. doi: 10.21037/qims-23-1737. Epub 2024 Jul 11.
3
Comparison between thermal ablation and surgery in low risk papillary thyroid carcinoma: a prospective study.热消融与手术治疗低危甲状腺微小乳头状癌的前瞻性对比研究。
Front Endocrinol (Lausanne). 2024 Aug 1;15:1398208. doi: 10.3389/fendo.2024.1398208. eCollection 2024.
4
The safety and efficacy of delayed surgery by simulating clinical progression of observable papillary thyroid microcarcinoma: a retrospective analysis of 524 patients from a single medical center.通过模拟可观察到的甲状腺微小乳头状癌临床进展来延迟手术的安全性和有效性：来自单一医疗中心的524例患者的回顾性分析
Front Oncol. 2023 Oct 10;13:1046014. doi: 10.3389/fonc.2023.1046014. eCollection 2023.
5
Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration.放射性碘辅助治疗分化型甲状腺癌：更新与再思考。
Front Endocrinol (Lausanne). 2022 Nov 30;13:994288. doi: 10.3389/fendo.2022.994288. eCollection 2022.
6
Large-Volume Lateral Lymph Node Metastasis Predicts Worse Prognosis in Papillary Thyroid Carcinoma Patients With N1b.大体积侧颈部淋巴结转移预示 N1b 期甲状腺乳头状癌患者预后更差。
Front Endocrinol (Lausanne). 2022 Feb 2;12:815207. doi: 10.3389/fendo.2021.815207. eCollection 2021.
7
Qin's seven steps for endoscopic selective lateral neck dissection via the chest approach in patients with papillary thyroid cancer: experience of 35 cases.秦氏经胸入路内镜下甲状腺癌选择性颈侧区清扫术七步法:35 例经验总结。
Surg Endosc. 2022 Apr;36(4):2524-2531. doi: 10.1007/s00464-021-08540-9. Epub 2021 Jul 6.
8
Prediction of ipsilateral lateral cervical lymph node metastasis in papillary thyroid carcinoma: a combined dual-energy CT and thyroid function indicators study.预测甲状腺乳头状癌同侧颈侧区淋巴结转移：一项联合双能 CT 和甲状腺功能指标的研究。
BMC Cancer. 2021 Mar 4;21(1):221. doi: 10.1186/s12885-021-07951-0.
Zotero 插件